veterinary – pharmaceutical daily

January 23, 2017 Off

Swedish Oasmia targets $16B worth US animal health care market

A swedish oncology company Oasmia Pharmaceutical AB, which works on finding cancer cures for animals and humans, said it would move its veterinary assets to the United States.

January 5, 2017 Off

Valneva, Merck in new animal vaccines deal (U.S.&Canada)

By Dino Mustafić

Valneva has given Merck in United States and Canada rights to use its EB66 technology to research new veterinary vaccines.

September 9, 2016 Off

First Dechra’s FDA approval for US generic entrant antibiotic

By Dino Mustafić

Dechra, an international specialist veterinary pharmaceuticals company, has received approval from the U.S. Food and Drug Administration (FDA) for a generic antibiotic.